
The FAVOR III trial
@favoriiitrial
The FAVOR III Europe Japan Trial
QFR vs. FFR randomized non-inferiority trial
2000 patients in 35 European and Japanese heart centres
ID: 1161268058603831296
13-08-2019 13:27:35
14 Tweet
156 Followers
60 Following

Yesterday, the team by Dr. Barbara Stähli, Universitäres Herzzentrum Zürich, Switzerland, randomized their first patient in the 2000 pts The FAVOR III trial. #QFR #coronaryphysiology #cardiotwitter Ole Fröbert Jelmer Westra Dr Koltowski Niels R. Holm Javier Escaned Gianluca Campo


The FAVOR III trial news! Dr. Koltowski and colleagues enrolled their first patient at Warsaw University Hospital today. Congratulations! #QFRfirst Dr Koltowski Jelmer Westra Gianluca Campo Javier Escaned Evald Høj Christiansen Ole Fröbert Ashkan Eftekhari Troels Thim Simone Biscaglia Niels R. Holm


What a start by Prof. Gianluca Campo, Simone Biscaglia and their dream team in Ferrara!! Two first Italian patients enrolled in 24h in the The FAVOR III trial. #QFR vs FFR in 2000 pts. Ole Fröbert Jelmer Westra Ashkan Eftekhari Dr Koltowski Niels R. Holm Javier Escaned


Great news from the The FAVOR III trial! Today, Dr. Liu and the team at Hagaziekenhuis in The Hague became the 7th site to begin enrolment in this exciting trial on #QFR vs FFR #QFRFirst


A true landmark was reached in the The FAVOR III trial today! First Spanish patient enrolled by Dr. Hernán Mejía Rentería and the team at Hospital Clínico San Carlos, Madrid in a successful #QFR procedure. Congratulations! Javier Escaned Niels R. Holm Birgitte Krogsgaard Jelmer Westra Evald Høj Christiansen


The second French center has now started active enrolment in the The FAVOR III trial! Congrats to Julienadjedj and his team at Institut Arnault Tzcank in Nice for enrolling their first two FAVOR III patients this week. Many thanks for your contribution on #QFR vs FFR!


Great news in the The FAVOR III trial! Yesterday, Dr. Thue Olsen and the FAVOR III team randomized their first patient at Gentofte Hospital, Denmark. Congratulations! #QFR #coronaryphysiology #cardiotwitter Thue Olsen Niels R. Holm Evald Høj Christiansen


Great start to a new week! Dr. Bruno Farah and his team at Clinique Pasteur, Toulouse, just enrolled their first patient in the The FAVOR III trial. Congratulations! #QFR Niels R. Holm Birgitte Krogsgaard Jelmer Westra Evald Høj Christiansen Ashkan Eftekhari


It is a great week in the The FAVOR III trial. Yet another center starting active enrolment! Many thanks to Dr. Karsten Lenk and his team at University Clinic Leipzig for their engagement in this important trial on #QFR vs. FFR. Niels R. Holm Evald Høj Christiansen Ashkan Eftekhari Birgitte Krogsgaard


The FAVOR III trial News! Two great Italian centers just enrolled their first patient. Congratulations to the teams at University Napoli Federico II and Arcispedale S. Maria Nuova di Reggio Emilia. Good job! Luigi Di Serafino @Iginio51341807 Giovanni Esposito #QFR


First enrolment at Charite - Universitätsmedizin this morning! Congratulations to Prof. Dr. med. Ulf Landmesser and his team. This is great news for the The FAVOR III trial!


This morning, we reached a major milestone in the FAVOR III trial! Patient number 500 was enrolled by dr. Hernán Mejía-Renteria and his colleagues at Hospital Clinico San Carlos, Madrid. Beyond grateful for the collaboration! #QFR Niels R. Holm Evald Høj Christiansen Birgitte Krogsgaard HernánMR


Yesterday, prof. Gianluca Campo and his team in Ferrara enrolled patient no 1000 in the The FAVOR III trial. Ferrara is also the top enrolling center followed by Sahlgenska, Sweden and Clinique Axium, Aix-en-Provence, France. Simone Biscaglia Tebaldi Matteo Niels R. Holm
